AIA
ABBV icon

Accelerate Investment Advisors’s AbbVie ABBV Stock Holding History

Accelerate Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$384K Sell
1,764
-225
-11% -$49.9K 0.26% 58
2025
Q4 		$454K Buy
1,989
+204
+11% +$46.5K 0.31% 48
2025
Q3 		$413K Buy
1,785
+3
+0.2% +$611 0.28% 55
2025
Q2 		$331K Buy
1,782
+628
+54% +$117K 0.25% 66
2025
Q1 		$242K Sell
1,154
-83
-7% -$16.1K 0.2% 84
2024
Q4 		$220K Buy
1,237
+127
+11% +$23.4K 0.19% 87
2024
Q3 		$219K Buy
+1,110
New +$207K 0.21% 74

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Accelerate Investment Advisors's ABBV Position: Q1 2026 in Review

Accelerate Investment Advisors reduced its AbbVie (ABBV) stake by 11% in Q1 2026, selling an estimated $49.9K and leaving 1,764 shares worth $384K. The position accounts for 0.26% of the portfolio, ranked #58.

Accelerate Investment Advisors first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. The position peaked at $454K in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Accelerate Investment Advisors held 1,764 shares of AbbVie worth $384K as of Q1 2026.
  • Accelerate Investment Advisors sold 225 AbbVie shares in Q1 2026, an estimated $49.9K.
  • AbbVie made up 0.26% of Accelerate Investment Advisors's portfolio in Q1 2026, its #58 holding.
  • Accelerate Investment Advisors first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
  • Accelerate Investment Advisors's AbbVie position peaked at $454K in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Accelerate Investment Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.